Cellaïon
La BCE indique pour Cellaïon la situation juridique 012 (Registre : dissolution ou liquidation) ; c'est l'état actuel selon le registre lui-meme, qui ne mentionne pas de date de debut. Les comptes annuels de 2024 montrent des capitaux propres négatifs (€-13,85M) et un résultat net de €-7,71M.
| Capitaux propres | €-13,85M |
| Résultat net | €-7,71M |
| Effectif (ETP) | 15,5 |
| Mieux que le secteur | 5% |
Profil fragile, attention surtout à santé.
Les 5 axes sont calculés sur des données lues par Checked.
Dissolution ou liquidation
Le registre BCE indique que cette entreprise est en cours de cessation. Une probabilité de faillite à douze mois n'a alors plus de sens, nous n'affichons donc pas de chiffre.
Le détail complet du score, son historique par exercice et la limite de crédit indicative figurent dans Kantoor S.
Voir les plans →| Indicateur | Cette entreprise | Médiane du secteur | Position dans le secteur |
|---|---|---|---|
| Solvabilité | -592,9% | 51,8% | |
| Résultat net | €-7,71M | €51k | |
| Capitaux propres | €-13,85M | €126k | |
| Marge brute d'exploitation | €-4,03M | €148k | |
| Frais de personnel | €3,41M | €161k |
Afficher 11 autres indicateurs
| Exercice | 2024 |
|---|---|
| Dépôt | volledig |
| Chiffre d'affaires | - |
| EBITDA | €-7,58M |
| Résultat net | €-7,71M |
| Cash-flow | €-7,60M |
| Frais de personnel | €3,41M |
| Impôts sur le résultat | €2k |
| Dividendes | - |
| Total actif | €2,34M |
| Capitaux propres | €-13,85M |
| Dettes | €15,10M |
| dont ≤ 1 an | €2,50M |
| dont > 1 an | €12,61M |
| Fonds de roulement | €-376k |
| Employés (ETP) | 15,5 |
| 2024 | |
|---|---|
| Current ratio | 0,85 |
| Quick ratio | 0,85 |
| Ratio fonds de roulement | -16,1% |
| Solvabilité | -592,9% |
| Debt / equity | -1,09 |
| Endettement à long terme | -0,91 |
| Interest coverage | -105,13 |
| Rentabilité brute | - |
| Rentabilité nette | - |
| ROA | -330,1% |
| ROE | 55,7% |
| Marge EBITDA | - |
| Crédit clients (DSO) | - |
| Crédit fournisseurs (DPO) | 174d |
| Rotation des stocks | - |
| Jours de stock (DSI) | 0d |
Comptes annuels complets (27 postes)
| Poste | Code | 2024 |
|---|---|---|
| Bilan, Actif | ||
| TOTAL DE L'ACTIF | 20/58 | €2,34M |
| Actifs immobilisés | 21/28 | €214k |
| Frais d'établissement | 20 | €0 |
| Immobilisations incorporelles | 21 | €0 |
| Immobilisations corporelles | 22/27 | €0 |
| Immobilisations financières | 28 | €214k |
| Actifs circulants | 29/58 | €2,12M |
| Stocks et commandes en cours | 3 | €0 |
| Créances à un an au plus | 40/41 | €869k |
| Valeurs disponibles | 54/58 | €1,25M |
| Bilan, Passif | ||
| TOTAL DU PASSIF | 10/49 | €2,34M |
| Capitaux propres | 10/15 | €-13,85M |
| Apport / capital | 10/11 | €7,09M |
| Bénéfice (perte) reporté(e) | 14 | €-20,94M |
| Provisions et impôts différés | 16 | €1,08M |
| Dettes | 17/49 | €15,10M |
| Dettes à plus d'un an | 17 | €12,61M |
| Dettes à un an au plus | 42/48 | €2,50M |
| Dettes commerciales à un an au plus | 44 | €2,49M |
| Compte de résultats | ||
| Marge brute d'exploitation | 9900 | €-4,03M |
| Résultat d'exploitation | 9901 | €-7,69M |
| Produits financiers | 75 | €53k |
| Charges financières | 65 | €72k |
| Résultat avant impôts | 9903 | €-7,71M |
| Impôts sur le résultat | 67/77 | €2k |
| Résultat de l'exercice | 9904 | €-7,71M |
| Résultat à affecter | 9905 | €-7,71M |
| NACE primaire | Activités dans le domaine de l’alimentation(86995) |
| Forme juridique | SA(014) |
| Date de constitution | 02-03-2021 |
| Status | Actif |
| Code postal | 1435 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active, pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 25020B0074/00B002 | Wallonie | 6,2 ha | 1 · 17 m² | 7,8 m · 2 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise, publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
Nous connaissons 11 actes du Moniteur belge pour cette entreprise. Aucun n'a encore été lu : ce qui s'y trouve n'a ici été ni constaté ni réfuté.
15-07-2024 Dissolution et clôture immédiate de la liquidation
- Ontbinding: 2024-06-03
Détails techniques
{
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"auditor": null,
"act_meta": {
"language": "mixed",
"pub_date": "2024-07-15",
"filing_date": null,
"act_kind_objet": "DISSOLUTION DE LA SOCIETE - NOMINATION D\u0027UN LIQUIDATEUR-"
},
"decision": {
"body": "assembl\u00E9e_g\u00E9n\u00E9rale_extraordinaire",
"act_date": "2024-06-03",
"unanimous": null
},
"end_event": {
"reason": "Dissolution par assembl\u00E9e g\u00E9n\u00E9rale",
"art_wvv": [
"2:88"
],
"sub_type": "voluntary_dissolution_with_close",
"closure_effective_date": null,
"dissolution_effective_date": "2024-06-03",
"closure_effective_date_is_approximate": false,
"dissolution_effective_date_is_approximate": false
},
"liquidator": {
"kind": "org",
"org_kbo": "0432.711.951",
"org_name": "Janson",
"person_dob": null,
"person_rrn": null,
"is_judicial": false,
"person_name": null,
"is_remunerated": true,
"person_address": null,
"person_birth_place": null
},
"silent_merger": null,
"court_division": {
"name": "TRIBUNAL BE L\u0027ENTREPRISE DU BRABANT WALLON",
"language": "fr",
"tribunal_type": "entreprise"
},
"books_custodian": null,
"subject_company": {
"kbo": "0764.522.425",
"name_full": "Cella\u00EFon",
"legal_form": "SA"
},
"closure_mandatary": null,
"prior_opening_ref": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Kim Lagae",
"org_rep_person_name": null
},
"co_filed_documents": [
"une exp\u00E9dition conforme de l\u0027acte",
"des procurations",
"le rapport sp\u00E9cial \u00E9tabli par le conseil d\u0027administration conform\u00E9ment \u00E0 l\u0027article 2:71 \u00A72 du Code des soci\u00E9t\u00E9s et des associations",
"le rapport sp\u00E9cial \u00E9tabli par le commissaire conform\u00E9ment \u00E0 l\u0027article 2:71 \u00A72 du Code des soci\u00E9t\u00E9s et des associations"
],
"real_estate_transferred": [],
"shareholder_loan_settled": null,
"financials_at_dissolution": null,
"distribution_to_shareholders": null
}23-06-2023 Augmentation de capital de 5.533.714 € à 21.620.314,02 €
- €16.086.600,02 → €21.620.314,02
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 21620314.02,
"delta_eur": 5533714.0,
"before_eur": 16086600.02,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": "B",
"n_new_shares": 55336,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 100.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 5533714.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-06-23",
"filing_date": "2023-06-21",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2023-06-13",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0764.522.425",
"name_full": "Cella\u00EFon",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"rapport sp\u00E9cial du conseil d\u0027administration",
"rapport du commissaire",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 256309,
"class_name": "B",
"capital_share_eur": 21620314.02,
"voting_rights_per_share": null
}
]
}02-02-2023 Augmentation de capital de 8.000.100 € à 16.086.600,01 €
- €8.086.500,01 → €16.086.600,01
Détails techniques
{
"events": [
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 16086600.01,
"delta_eur": 8000100.0,
"before_eur": 8086500.01,
"share_emission": {
"agio_eur": 800010.01,
"share_form": "nominal",
"share_class": "B",
"n_new_shares": 80001,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.01
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 8000100.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 80001,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim LAGAE",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-02-02",
"filing_date": "2023-01-31",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2022-12-29",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0764.522.425",
"name_full": "Cella\u00EFon",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition conforme de l\u0027acte",
"procurations",
"Rapport sp\u00E9cial du conseil d\u0027administration",
"Rapports du commissaire",
"coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": null,
"class_name": "Ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": null,
"class_name": "Ordinaires sans droit de vote",
"capital_share_eur": null,
"voting_rights_per_share": 0.0
},
{
"n_shares": null,
"class_name": "Classe B",
"capital_share_eur": null,
"voting_rights_per_share": 2.0
}
]
}09-02-2022 Opération sur le capital ou les actions
Détails techniques
{
"events": [],
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2022-01-28",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2022-01-17",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0764.522.425",
"name_full": "PROMETHERA BIOSCIENCES Thuofeutico",
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Kim Lagae",
"org_rep_person_name": null,
"person_role_at_subject": "notaire instrumentant"
},
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte"
],
"shareholders_after": [],
"share_classes_after": []
}26-01-2022 Augmentation de capital
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 5371749.98,
"delta_eur": 5210249.98,
"before_eur": 61500.0,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 52102,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 5210249.98,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"_arith_inconsistent": true,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 8086500.0,
"delta_eur": 2814750.02,
"before_eur": 5371749.98,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 28648,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 100.0
},
"decrease_purpose": null,
"contribution_type": "natura",
"paid_up_delta_eur": 2814750.02,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"_arith_inconsistent": true,
"merger_new_shares_n": 28648,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "actions_ordinaires_sans_droit_de_vote",
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": 1.0,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Abda Lilly SRL",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "A Q Invest SRL",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "actions_ordinaires_sans_droit_de_vote",
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": 1.0,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2022-01-26",
"filing_date": "2022-01-24",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2022-01-17",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2022-01-17"
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": null
},
"subject_company": {
"kbo": "0764.522.425",
"name_full": "Promethera Therapeutics",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal avec annexes",
"procurations",
"rapport sp\u00E9cial du conseil d\u0027administration",
"rapports du commissaire",
"coordination des statuts"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Abda Lilly SRL",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "A Q Invest SRL",
"role": null,
"n_shares": null,
"share_class": null
}
],
"share_classes_after": [
{
"n_shares": 107534,
"class_name": "actions_ordinaires",
"capital_share_eur": 8086500.01,
"voting_rights_per_share": 1.0
},
{
"n_shares": 26669,
"class_name": "actions_ordinaires_sans_droit_de_vote",
"capital_share_eur": 0.01,
"voting_rights_per_share": 0.0
}
]
}| Dénomination légaleFR | Cellaïon |